Orthofix has announced the full market launch of Opus BA, a synthetic bioactive bone graft solution for cervical and lumbar spine fusion procedures.
Available in putty and strip formulations, Opus BA can be used to fill bone voids or gaps in the skeletal system that are not intrinsic to the stability of bony structure. Opus BA acts as a scaffold allowing bone growth across the surface that is reabsorbed and replaced with natural bone during the healing process. Easily hydrated with autogenous bone marrow or autograft with saline, Opus BA is mouldable and ideal for versatile applications, say Orthofix.
Kevin Kenny, president of Orthofix Global Spine, said: “Bioactive synthetics are a very large and growing market. We recognise that each bone substitute has its own unique advantages and surgeons have different preferences when evaluating the use of autologous, allogeneic or synthetic bone graft materials for their patients.
“The addition of Opus BA is another example of our commitment to providing surgeons with a wide range of solutions so they can select the best bone substitute for each patient.”
According to Orthofix, Opus BA’s osteoconductive matrix is made up of a carefully selected mix of components: carbonate apatite bone mineral, bioactive glass, and Type 1 Collagen carrier. These materials were selected for the ability to stimulate the growth, formation and resorption of bone. Opus BA undergoes a proprietary process to ensure the osteoconductive matrix has uniform distribution, mimicking the structure and porosity of cancellous bone, the company adds.
